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Results
A distinctive protein band was visible in the treated patient columns at ap-
proximately 60 kDa in all of the patients (Figure 5). The MS analysis (Fig-
ure 6) revealed 23 of 164 proteins was significantly changed after treat-
ment (Table 1). The expression of five proteins were down-regulated and 
18 were upregulated. In the band between 50 and 70 kDA we found a 
significant elevation of clusterin (P = 0.0022), vitamin D binding protein 
(DPB) (P = 0.026) and cartilage acidic protein1 (CAP1) (P = 0.045).
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Background and aims
Intraarticular gold may decrease osteoarthritis (OA) inflammation. Gold 
implant treatment correlate with clinically significant improvements in joint 
movement and pain management. Gold may decrease inflammation because 
of various mechanisms such as regulation of the NF-kB (nuclear factor kap-
pa-light-chain-enhancer of activated B cells) pathway (Figure 1 - 4) (1-6).
The aim of this study was to investigate if treatment with intra-articular 
solid gold micro particles induces any significant proteomic changes in the 
synovial fluid (SF) in knee OA. 
Methods
A cohort of 30 patients, aged ≥18years, pain ≥ 3 months, synovial effusion 
on MRI, and Kellgren-Lawrence OA grade 3-4 were included. Metallic gold 
20 mg, 72.000 pieces, 20-40 µ-meter (Berlock-Micro-Implants, Human-
GoldInject) (7-9) were injected into the knee joint using the patient’s own 
synovial fluid as the carrier. 
SF samples was investigated, before and 8 weeks after treatment in 17 pa-
tients. To determine protein concentration, a bicinchoninic acid (BCA) as-
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Conclusions
The elevated clusterin may be a sign of increased protection of cartilage 
and cells, which correlates with a regulation of the NF-kB pathway. DBP 
correlate with increased vitamin D level, but the overall effect is uncertain. 
CAP1 has been found to marker of mesenchymal stem cells undergoing 
chondrogenic differentiation. It is shown that gold microparticles induce 
differentiation of mesenchymal stem cells. This indicate gold particles in-
duce chondrogenic differentiation of resident mesenchymal stem cells.
We hypothesize gold particles inhibit macrophage mediated inflamma-
tion, induce chondrogenic differentiation of resident mesenchymal stem 
cells and stimulate the release of cartilage protective protein. Not all regu-
lated proteins were correlated with positive effects on OA and some incon-
clusive. Further studies need to investigate the mechanism and proteins in-
volved in gold treatment of OA.
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Figure 1. Macrophages controls the dissolution membrane which liberate the gold ions 
by oxidation of the surface. Once the ions are liberated, most likely as Au(CN) , they are 
free to diffuse through the immediate microenvironment. The gold-loaded molecules 
are taken up into the cells, primarily  macrophages, mastcells and histocytes. 
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Figure 2. Close to the gold implant gold-loaded molecular clusters 
are located outside cells. The two loaded cells are believed to be 
macrophages loaded with gold ions. The gold ions accumulate pri-
marily in the lysosymes (3).
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Figure 3. Once in the intercellular fluid and the intracellular compart-
ments, the gold ions act in the same ways that have been demonstrated 
for systemically administered gold ions. The effect is related to the abili-
ty of the gold ions to unfold the protein structures.
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Figure 4. Gold ions suppress inflammation locally by affecting certain signalling 
molecules and binding enzymes essential for the inflammatory process. The DNA 
binding activity and transcription regulation of NF-kB is abolished when AU- ions 
replace Zn2+ ions. (4)
Figure 5. SDS-PAGE showing paired patients where the number identifies 
the patient and the ‘a’ or ‘b’ indicates if it is prior to or after treatment 
respectively. The column furthest to the left is the BroadRange Unstained 
Protein Ladder. Each gel contains four paired patients, before and after 
treatment, and one unpaired patient after treatment in the last column.
Figure 6. A scheme showing the chronological workflow of filtrations and MS anal-
yses performed in Perseus Version 1.6.5.0 to investigate the proteomic changes of 
the samples.
Protein names     Gene    Regulation  Fold    P-value
       Names       change 
Aggrecan core protein   2 ACAN   Up    0.49    0.0081
Alpha-1-acid glycoprotein    2 ORM2    Down    -0.39    0.0001
Apolipoprotein      C-III APOC3  Down   -0.25    .0424
Cartilage acidic protein 1    CRTAC1    Up     0.21     0.0446
Cartilage oligomeric matrix protein COMP    Up     0.33     0.0038
Clusterin       CLU     Up     0.28     0.0022
Complement component C6   C6     Down    -0.34    0.0142
Complement component C8 g-chain C8G     Up     0.30     0.0195
Complement factor D    CFD     Up     0.47     0.0134
Complement factor H-related 1  CFHR1    Up     0.86     0.0049
Gelsolin       GSN    Up     0.26     0.0075
Hemoglobin subunit delta    HBD    Up     1.06     0.0398
Hemopexin      HPX     Down    -0.11    0.0369
Ig gamma-1 chain C region   IGHG1    Up     0.32     0.0035
Ig gamma-2 chain C region   IGHG2    Up     0.35     0.0043
Ig kappa chain C region    IGKC    Up     0.29     0.0337
Ig mu chain C region     IGHM    Up     0.25     0.0261
Monocyte differentiation antigen  CD14   Up     0.67     0.0269
Tetranectin      CLEC3B    Up     0.16     0.0455
Thyroxine-binding globulin   SERPINA7  Up     0.19     0.0005
Transforming growth factor  TGFBI    Down    -0.41    0.0332
Versican core protein    VCAN    Up     0.41     0.0355
Vitamin D-binding protein   GC     Up     0.15     0.0257
say was used. Gel electrophoresis by SDS-PAGE was used to visualize the 
synovial proteome and relative qualitative changes between the treated 
and untreated samples. Mass spectrometry sample preparation was per-
formed with filter aided sample preparation (FASP). The global proteome 
was investigated through LC-MS/MS in Orbitrap Q Exactive 
Table 1. Results from paired t-test showing proteins with significantly altered expression between samples be-
fore treatment and samples post treatment. The figure also shows the gene names of the proteins, the fold-
change in expression and p-values.
